Are anandamide and cannabinoid receptors involved in ethanol tolerance? A review of the evidence

Alcohol and Alcoholism

Volumn 35, Issue 2, 2000, Pages 126-133

  Hungund, B L ^a,b   Basavarajappa, B S ^a  

^a NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^b NYS Psychiatric Institute at NKI ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; ANANDAMIDE; CANNABINOID RECEPTOR; CANNABINOID RECEPTOR ANTAGONIST; CANNABIS; DRONABINOL; GUANINE NUCLEOTIDE BINDING PROTEIN; GUANOSINE 5' O (3 THIOTRIPHOSPHATE); ION CHANNEL; RIMONABANT;

ALCOHOL TOLERANCE; ALCOHOLISM; ANIMAL BEHAVIOR; ARTICLE; BEHAVIOR MODIFICATION; DOPAMINERGIC SYSTEM; DRUG CROSS TOLERANCE; HUMAN; LIMBIC SYSTEM; NEUROMODULATION; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BINDING; RECEPTOR DOWN REGULATION; SECOND MESSENGER; SIGNAL TRANSDUCTION; SYNAPTIC MEMBRANE;

ANIMALIA; CANNABIS; CANNABIS SATIVA; MAMMALIA;

EID: 0034018628     PISSN: 07350414     EISSN: None     Source Type: Journal    
DOI: 10.1093/alcalc/35.2.126     Document Type: Article

References (117)

1. Amit, Z. and Brown, Z. W. (1982) Actions of drugs of abuse on brain reward systems: a reconsideration with specific attention to alcohol. Pharmacology, Biochemistry and Behavior 17, 233-238.
2. Arendt, T., Allen, Y., Sinden, J., Schugens, M. M., Marchbanks, R. M., Lantos, P. L. and Gray, J. A. (1988a) Cholinergic-rich brain transplants reverse alcohol-induced memory deficits. Nature 332, 448-450.
3. Arendt, T., Henning, D., Gray, J. A. and Marchbanks, R. (1988b) Loss of neurons in the rat basal forebrain cholinergic projection system after prolonged intake of ethanol. Brain Research Bulletin 21, 563-569.
4. 1) receptors. Psychopharmacology 132, 104-106.
5. Audette, C. A., Burstein, S. H., Doyle, S. A. and Hunter, S. A. (1991) G-protein mediation of cannabinoid-induced phospholipase activation. Pharmacology, Biochemistry and Behavior 40, 559-563.
6. Basavarajappa, B. S. and Hungund, B. L. (1999a) Chronic ethanol increases the cannabinoid receptor agonist, anandamide and its precursor N-arachidonyl phosphatidyl ethanolamine in SK-N-SH cells. Journal of Neurochemistry 72, 522-528.
7. 35S] GTPγ S binding in synaptic plasma membrane from chronic ethanol exposed mouse. Brain Research 815, 89-97.
8. 2 in human neuroblastoma cells after chronic alcohol exposure: prevention by GM1 ganglioside. Alcoholism: Clinical and Experimental Research 21, 1199-1203.
9. Basavarajappa, B. S., Cooper, T. B. and Hungund, B. L. (1998a) Chronic ethanol administration down-regulates cannabinoid receptors in mouse brain synaptic plasma membrane. Brain Research 793, 212-218.
10. 2. Biochemical Pharmacology 55, 515-521.
11. Bhave, S. V., Ghoda, L. and Hoffman, P. L. (1999) Brain-derived neurotrophic factor mediates the anti-apoptotic effect of NMDA in cerebellar granule neurons: signal transduction cascades and site of ethanol action. Journal of Neuroscience 19, 3277-3286.
12. Blum, K., Hudson, K. C., Friedman, R. N. and Wallace, J. E. (1975) Tetrahydrocannabinol: inhibition of alcohol-induced withdrawal symptoms in mice. In Drug Addiction Vol. 3, Neurobiology and Influences on Behavior, Singh, J. and Lal, H. eds, pp. 39-53. Stratton Intercon Med. Book Corp., New York.
13. Brodie, M. S., Shefner, S. A. and Dunwiddie, T. V. (1990) Ethanol increases the firing rate of dopamine neurons of the rat ventral tegmental area in vitro. Brain Research 508, 65-69.
14. Burstein, S., Budrow, J., Debatis, M., Hunter, S. A. and Subramanian, A. (1994) Phospholipase participation in cannabinoid-induced release of free arachidonic acid. Biochemical Pharmacology 48, 1253-1264.
15. Calkin, P. A. and Barnes, E. M. J. (1994) Gamma-aminobutyric acid-A (GABAA) agonists down-regulate GABAA/benzodiazepine receptor polypeptides from the surface of chick cortical neurons. Journal of Biological Chemistry 269, 1548-1553.
16. Carlini, E. A. (1968) Tolerance to chronic administration of Cannabis saliva (marihuana) in rats. Pharmacology 1, 135-142.
17. Castellano, C., Cabib, S., Palmisano, A., Di Marzo, V. and Puglisi-Allegra, S. (1997) The effects of anandamide on memory consolidation in mice involve both D1 and D2 dopamine receptors. Behavioural Pharmacology 8, 707-712.
18. Caulfield, M. P. and Brown, D. A. (1992) Cannabinoid receptor agonists inhibit Ca current in NG108-15 neuroblastoma cells via a pertussis toxin-sensitive mechanism. British Journal of Pharmacology 106, 231-232.
19. Charness, M. E., Querimit, L. A. and Henteleff, M. (1988) Ethanol differentially regulates G proteins in neural cells. Biochemical and Biophysical Research Communications 155, 138-143.
20. Coe, I. R., Yao, L., Diamond, I. and Gordon, A. S. (1996) The role of protein kinase C in cellular tolerance to ethanol. Journal of Biological Chemistry 271, 29468-29472.
21. Colombo, G., Agabio, R., Fa, M., Guano, L., Lobina, C., Loche, A., Reali, R. and Gessa, G. (1998) Reduction of voluntary ethanol intake in ethanol-preferring sP rats by the cannabinoid antagonist SR-141716. Alcohol and Alcoholism 33, 126-130.
22. Consroe, P. (1998) Brain cannabinoid systems as targets for the therapy of neurological disorders. Neurobiology of Disease 5, 534-551.
23. Cook, S. A., Lowe, J. A. and Martin, B. R. (1998) CB1 receptor antagonist precipitates withdrawal in mice exposed to delta 9-tetrahydrocannabinol. Journal of Pharmacology and Experimental Therapeutics 285, 1150-1156.
24. Darden, J. H. and Hunt, W. A. (1977) Reduction of striatal dopamine release during an ethanol withdrawal syndrome. Journal of Neurochemistry 29, 1143-1145.
25. Davis, V. E. and Walsh, M. J. (1970) Alcohol, amines, and alkaloids: a possible biochemical basis for alcohol addiction. Science 167, 1005-1007.
26. Davis, W. M., Smith, S. G. and Werner, T. E. (1978) Noradrenergic role in the self-administration of ethanol. Pharmacology, Biochemistry and Behavior 9, 369-374.
27. Deadwyler, S. A., Heyser, C. J., Michaelis, R. C. and Hampson, R. E. (1990) The effects of delta-9-THC on mechanisms of learning and memory. National Institute of Drug Abuse Research Monograph 97, 79-93.
28. Deadwyler, S. A., Hampson, R. E., Mu, J., Whyte, A. and Childers, S. (1995a) Cannabinoids modulate voltage sensitive potassium A-current in hippocampal neurons via a cAMP-dependent process. Journal of Pharmacology and Experimental Therapeutics 273, 734-743.
29. Deadwyler, S. A., Heyser, C. J. and Hampson, R. E. (1995b) Complete adaptation to the memory disruptive effects of delta-9-THC following 35 days of exposure. Neuroscience Research Communications 17, 9-18.
30. Deitrich, R. A., Dunwiddie, T. V., Harris, R. A. and Erwin, V. G. (1989) Mechanism of action of ethanol: initial central nervous system actions. Pharmacological Reviews 41, 489-537.
31. Devane, W. A., Hanus, L., Breuer, A., Pertwee, R. G., Stevenson, L. A., Griffin, G., Gibson, D., Mandelbaum, A., Etinger, A. and Mechoulam, R. (1992) Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 258, 1946-1949.
32. Dewey, W. L. (1986) Cannabinoid pharmacology. Pharmacological Reviews 38, 151-178.
33. Di Marzo, V., Melck, D., Bisogno, T. and De Petrocellis, L. (1998) Endocannabinoids: endogenous cannabinoid receptor ligands with neuromodulatory action. Trends in Neurosciences 21, 521-528.
34. Diamond, I. and Gordon, A. S. (1997) Cellular and molecular neuroscience of alcoholism. Physiological Reviews 77, 1-20.
35. Dill, J. A. and Howlett, A. C. (1988) Regulation of adenylate cyclase by chronic exposure to cannabimimetic drugs. Journal of Pharmacology and Experimental Therapeutics 244, 1157-1163.
36. Docherty, J. M., Harding, S. and Grupp, L. A. (1993) Reduction of ethanol intake by aerosol inhalation of a beta-adrenergic agonist: new route - new treatment approach? Alcoholism: Clinical and Experimental Research 17, 1051-1054.
37. Fadda, F. and Rossetti, Z. L. (1998) Chronic ethanol consumption: from neuroadaptation to neurodegeneration. Progress in Neurobiology 56, 385-431.
38. Fadda, F., Mosca, E., Meloni, R. and Gessa, G. L. (1985) Ethanol-stress interaction on dopamine metabolism in the medial prefrontal cortex. Alcohol and Drug Research 6, 449-454.
39. Fan, F., Tao, Q., Abood, M. and Martin, B. R. (1996) Cannabinoid receptor down-regulation without alteration of the inhibitory effect of CP 55,940 on adenyl cyclase in the cerebellum of CP 55,940-tolerant mice. Brain Research 706, 13-20.
40. Follesa, P. and Ticku, M. K. (1995) Chronic ethanol treatment differentially regulates NMDA receptor subunit mRNA expression in rat brain. Molecular Brain Research 29, 99-106.
41. Follesa, P. and Ticku, M. K. (1996) Chronic ethanol-mediated up-regulation of the N-methyl-D-aspartate receptor polypeptide subunits in mouse cortical neurons in culture. Journal of Biological Chemistry 271, 13297-13299.
42. Fride, E. and Mechoulam, R. (1993) Pharmacological activity of the cannabinoid receptor agonist, anandamide, a brain constituent. European Journal of Pharmacology 231, 313-314.
43. Gallate, J. E. and McGregor, I. S. (1999) The motivation for beer in rats: effects of ritanserin, naloxone and SR 141716. Psychopharmacology 142, 302-308.
44. Gifford, A. N. and Ashby, C. R. J. (1996) Electrically evoked acetylcholine release from hippocampal slices is inhibited by the cannabinoid receptor agonist, WIN 55212-2, and is potentiated by the cannabinoid antagonist, SR 141716A. Journal of Pharmacology and Experimental Therapeutics 277, 1431-1436.
45. Gill, K. and Amit, Z. (1989) Serotonin uptake blockers and voluntary alcohol consumption. A review of recent studies. Recent Developments in Alcoholism 7, 225-248.
46. Goldstein, D. B. and Pal, N. (1971) Alcohol dependence produced in mice by inhalation of ethanol: grading the withdrawal reaction. Science 172, 288-290.
47. Gordon, A. S., Collier, K. and Diamond, I. (1986) Ethanol regulation of adenosine receptor-stimulated cAMP levels in a clonal neural cell line: an in vitro model of cellular tolerance to ethanol. Proceedings of the National Academy of Sciences of the USA 83, 2105-2108.
48. Grobin, A. C., Matthews, D. B., Devaud, L. L. and Morrow, A. L. (1998) The role of GABA(A) receptors in the acute and chronic effects of ethanol. Psychopharmacology (Berlin) 139, 2-19.
49. Hodges, H., Allen, Y., Sinden, J., Mitchell, S. N., Arendt, T., Lantos, P. L. and Gray, J. A. (1991) The effects of cholinergic drugs and cholinergic-rich fetal neural transplants on alcohol-induced deficits in radial maze performance in rats. Behavioural Brain Research 43, 7-28.
50. Hoffman, P. L. (1995) Glutamate receptors in alcohol withdrawal-induced neurotoxicity. Metabolic Brain Disease 10, 73-79.
51. Hollister, L. E. and Gillespie, H. K. (1970) Marihuana, ethanol, and dextroamphetamine. Mood and mental function alterations. Archives of General Psychiatry 23, 199-203.
52. Howlett, A. C. (1995) Pharmacology of cannabinoid receptors. Annual Review of Pharmacology and Toxicology 35, 607-634.
53. Howlett, A. C., Qualy, J. M. and Khachatrian, L. L. (1986) Involvement of Gi in the inhibition of adenylate cyclase by cannabimimetric drugs. Molecular Pharmacology 29, 307-313.
54. Hu, X. J. and Ticku, M. K. (1995) Chronic ethanol treatment up-regulates the NMDA receptor function and binding in mammalian cortical neurons. Molecular Brain Research 30, 347-356.
55. Hu, X. J., Follesa, P. and Ticku, M. K. (1996) Chronic ethanol treatment produces a selective upregulation of the NMDA receptor subunit gene expression in mammalian cultured cortical neurons. Molecular Brain Research 36, 211-218.
56. Hungund, B. L., Goldstein, D. B., Villegas, F. and Cooper, T. B. (1988) Formation of fatty acid ethyl esters during chronic ethanol treatment in mice. Biochemical Pharmacology 37, 3001-3004.
57. 2 activity in synaptosomal preparations from mice. Neurochemistry International 25, 321-325.
58. Hunt, W. A. (1985) Alcohol and Biological Membranes, pp. 130-144. The Guilford Press, New York.
59. Hunter, S. A., Burstein, S. and Renzulli, L. (1986) Effects of cannabinoids on the activities of mouse brain lipases. Neurochemical Research 11, 1273-1288.
60. Jones, R. T., Benowitz, N. L. and Herning, R. I. (1981) Clinical relevance of cannabis tolerance and dependence. Journal of Clinical Pharmacology 21 (Suppl.), 143S-152S.
61. Kalant, H. and LeBlanc, A. E. (1974) Effect of acute and chronic pretreatment with delta 1-tetrahydrocannabinol on motor impairment by ethanol in the rat. Canadian Journal of Physiology and Pharmacology 52, 291-297.
62. Kalant, H., LeBlanc, A. E. and Gibbins, R. J. (1971) Tolerance to, and dependence on, some non-opiate psychotropic drugs. Pharmacological Reviews 23, 135-191.
63. Kalluri, H. S., Mehta, A. K. and Ticku, M. K. (1998) Up-regulation of NMDA receptor subunits in rat brain following chronic ethanol treatment. Molecular Brain Research 58, 221-224.
64. Koob, G. F., Sanna, P. P. and Bloom, F. E. (1998) Neuroscience and addiction. Neuron 21, 467-476.
65. Laposata, E. A. and Lange, L. G. (1986) Presence of nonoxidative ethanol metabolism in human organs commonly damaged by ethanol abuse. Science 231, 497-499.
66. Littleton, J. and Little, H. (1994) Current concepts of ethanol dependence. Addiction 89, 1397-1412.
67. Lu, M. R., Wagner, G. C. and Fisher, H. (1993) Ethanol consumption following acute fenfluramine, fluoxetine, and dietary tryptophan. Pharmacology, Biochemistry and Behavior 44, 931-937.
68. Macdonald, R. L. (1995) Ethanol, γ-aminobutyrate type A receptors, and protein kinase C phosphorylation. Proceedings of the National Academy of Sciences of the USA 93, 3633-3635.
69. Mackie, K. and Hille, B. (1992) Cannabinoids inhibit N-type calcium channels in neuroblastoma-glioma cells. Proceedings of the National Academy of Sciences of the USA 89, 3825-3829.
70. Mackie, K., Devane, W. A. and Hille, B. (1993) Anandamide, an endogenous cannabinoid, inhibits calcium currents as a partial agonist in N18 neuroblastoma cells. Molecular Pharmacology 44, 498-503.
71. Mackie, K., Lai, Y., Westenbroek, R. and Mitchell, R. (1995) Cannabinoids activate an inwardly rectifying potassium conductance and inhibit Q-type calcium currents in AtT20 cells transfected with rat brain cannabinoid receptor. Journal of Neuroscience 15, 6552-6561.
72. Matsuda, L. A., Lolait, S. J., Brownstein, M. J., Young, A. C. and Bonner, T. I. (1990) Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 346, 561-564.
73. McMillan, D. E. and Snodgrass, S. H. (1991) Effects of acute and chronic administration of delta 9-tetrahydrocannabinol or cocaine on ethanol intake in a rat model. Drug and Alcohol Dependence 27, 263-274.
74. McQuilkin, S. J. and Harris, R. A. (1990) Factors affecting actions of ethanol on GABA-activated chloride channels. Life Sciences 46, 527-541.
75. Mechoulam, R. and Fride, E. (1995) The improved road to the endogenous brain cannabinoid ligands, the anandamides. In Cannabinoid Receptors, Pertwee, R. G., ed., pp. 233-258. Academic Press, New York.
76. Mechoulam, R., Ben-Shabat, S., Hanus, L., Ligumsky, M., Kaminski, N. E., Schatz, A. R., Gopher, A., Almog, S., Martin, B. R., Compton, D. R. et al. (1995) Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors. Biochemical Pharmacology 50, 83-90.
77. Melis, F., Stancampiano, R., Imperato, A., Carta, G. and Fadda, F. (1996) Chronic ethanol consumption in rats: correlation between memory performance and hippocampal acetylcholine release in vivo. Neuroscience 74, 155-159.
78. 36Cl-uptake in cerebral cortical synaptoneurosomes. Journal of Pharmacology and Experimental Therapeutics 246, 158-164.
79. Myers, R. D., Evans, J. E. and Yaksh, T. L. (1972) Ethanol preference in the rat: interactions between brain serotonin and ethanol, acetaldehyde, paraldehyde, 5-HTP and 5-HTOL. Neuropharmacology 11, 539-549.
80. Nevo, I. and Hamon, M. (1995) Neurotransmitter and neuromodulatory mechanisms involved in alcohol abuse and alcoholism. Neurochemistry International 26, 305-336.
81. Newman, L. M., Lutz, M. P., Gould, M. H. and Domino, E. F. (1972) 9-Tetrahydrocannabinol and ethyl alcohol: evidence for cross-tolerance in the rat. Science 175, 1022-1023.
82. Oviedo, A., Glowa, J. and Herkenham, M. (1993) Chronic cannabinoid administration alters cannabinoid receptor binding in rat brain: a quantitative autoradiographic study. Brain Research 616, 293-302.
83. Rabin, R. A. (1990) Chronic ethanol exposure of PC 12 cells alters adenylate cyclase activity and intracellular cyclic AMP content. Journal of Pharmacology and Experimental Therapeutics 252, 1021-1027.
84. Reid, L. D., Delconte, J. D., Nichols, M. L., Bilsky, E. J. and Hubbell, C. L. (1991) Tests of opioid deficiency hypotheses of alcoholism. Alcohol 8, 247-257.
85. Rinaldi-Carmona, M., Barth, F., Heaulme, M., Shire, D., Calandra, B., Congy, C., Martinez, S., Maruani, J., Neliat, G., Caput, D., Ferrara, P., Soubrie, P., Breliere, J. C. and Le Fur, G. (1994) SR141716A, a potent and selective antagonist of the brain cannabinoid receptor. FEBS Letters 350, 240-244.
86. Rinaldi-Carmona, M., Barth, F., Heaulme, M., Alonso, R., Shire, D., Congy, C., Soubrie, P., Breliere, J. C. and Le Fur, G. (1995) Biochemical and pharmacological characterization of SR141716A, the first potent and selective brain cannabinoid receptor antagonist. Life Sciences 56, 1941-1947.
87. Rodriguez de Fonseca, F., Gorriti, M. A., Fernandez-Ruiz, J. J., Palomo, T. and Ramos, J. A. (1994) Down-regulation of rat brain cannabinoid binding sites after chronic delta 9-tetrahydrocannabinol treatment. Pharmacology, Biochemistry and Behavior 47, 33-40.
88. 35S]guanylyl-5′O-(thio)-triphosphate binding in the basal ganglia of aged rats. Neuroscience 84, 1075-1083.
89. 35S]GTP gamma S binding and cannabinoid receptor mRNA levels in the basal ganglia and the cerebellum of adult male rats chronically exposed to delta 9-tetrahydrocannabinol. Journal of Molecular Neuroscience 11, 109-119.
90. Romero, J., Berrendero, F., Manzanares, J., Perez, A., Corchero, J., Fuentes, J. A., Fernandez-Ruiz, J. J. and Ramos, J. A. (1998c) Time-course of the cannabinoid receptor down-regulation in the adult rat brain caused by repeated exposure to delta 9-tetrahydrocannabinol. Synapse 30, 298-308.
91. Romero, J., Garcia, L., Fernandez-Ruiz, J. J., Cebeira, M. and Ramos, J. A. (1995) Changes in rat brain cannabinoid binding sites after acute and chronic exposure to their endogenous agonist, anandamide, or to δ 9-tetrahydrocannabinol. Pharmacology, Biochemistry and Behavior 51, 731-737.
92. Romero, J., Garcia-Palomero, E., Castro, J. G., Garcia-Gil, L., Ramos, J. A. and Fernandez-Ruiz, J. J. (1997) Effects of chronic exposure to delta 9-tetrahydrocannabinol on cannabinoid receptor binding and mRNA levels in several rat brain regions. Molecular Brain Research 46, 100-108.
93. Rossetti, Z. L., Hmaidan, Y. and Gessa, G. L. (1992) Marked inhibition of mesolimbic dopamine release: a common feature of ethanol, morphine, cocaine and amphetamine abstinence in rats. European Journal of Pharmacology 221, 227-234.
94. Rubino, T., Massi, P., Patrini, G., Venier, I., Giagnoni, G. and Parolaro, D. (1994) Chronic CP-55,940 alters cannabinoid receptor mRNA in the rat brain: an in situ hybridization study. NeuroReport 5, 2493-2496.
95. Rubino, T., Patrini, G., Parenti, M., Massi, P. and Parolaro, D. (1997) Chronic treatment with a synthetic cannabinoid CP-55,940 alters G-protein expression in the rat central nervous system. Molecular Brain Research 44, 191-197.
96. Salem, N. and Ward, G. (1993) The effects of ethanol on poly-unsaturated fatty acid composition. In Alcohol, Cell Membranes, and Signal Transduction in Brain. Alling, C., Diamond, I., Leslie, S. W., Sun, G. Y. and Wood, W. G. eds, pp. 33-46. Plenum Press, New York.
97. Samson, H. H. and Harris, R. A. (1992) Neurobiology of alcohol abuse. Trends in Pharmacological Sciences 13, 206-211.
98. Self, D. W. (1999) Anandamide: a candidate neurotransmitter heads for the big leagues. Nature Neuroscience 2, 303-304.
99. Siemens, A. J. and Doyle, O. L. (1979) Cross-tolerance between delta 9-tetrahydrocannabinol and ethanol: the role of drug disposition. Pharmacology, Biochemistry and Behavior 10, 49-55.
100. 35S]GPTgammaS autoradiography in rat brain. Journal of Neuroscience 16, 8057-8066.
101. Sprague, G. L. and Craigmill, A. L. (1976) Ethanol and delta-9-tetrahydrocannabinol: mechanism for cross-tolerance in mice. Pharmacology, Biochemistry and Behavior 5, 409-415.
102. Sprague, G. L. and Craigmill, A. L. (1978) Effects of two cannabinoids upon abstinence signs in ethanol-dependent mice. Pharmacology, Biochemistry and Behavior 9, 11-15.
103. Suzdak, P. D., Schwartz, R. D., Skolnick, P. and Paul, S. M. (1986) Ethanol stimulates γ-aminobutyric acid receptor mediated chloride transport in rat brain synaptoneurosomes. Proceedings of the National Academy of Sciences of the USA 83, 4071-4075.
104. Tabakoff, B., Whelan, J. P., Ovchinnikova, L., Nhamburo, P., Yoshimura, M. and Hoffman, P. L. (1995) Quantitative changes in G protein do not mediate ethanol-induced downregulation of adenylate cyclase in mouse cerebral cortex. Alcoholism: Clinical and Experimental Research 19, 187-194.
105. 35S]thio)triphosphate binding to membranes from human neuroblastoma SH-SY5Y cells. Molecular Pharmacology 47, 848-854.
106. Ulm, R. R., Volpicelli, J. R. and Volpicelli, L. A. (1995) Opiates and alcohol self-administration in animals. Journal of Clinical Psychiatry 56, 5-14.
107. US Public Health Service (1990) Seventh Annual Report to the US Congress on Alcohol and Health. National Institute of Alcohol Abuse and Alcoholism Public Health Service publication, Bethesda, MD.
108. Vogel, Z., Barg, J., Levy, R., Saya, D., Heldman, E. and Mechoulam, R. (1993) Anandamide, a brain endogenous compound, interacts specifically with cannabinoid receptors and inhibits adenylate cyclase. Journal of Neurochemistry 61, 352-355.
109. Wand, G. S., Diehl, A. M., Levine, M. A., Wolfgang, D. and Samy, S. (1993) Chronic ethanol treatment increases expression of inhibitory G-proteins and reduces adenylylcyclase activity in the central nervous system of two lines of ethanol-sensitive mice. Journal of Biological Chemistry 268, 2595-2601.
110. Wartmann, M., Campbell, D., Subramanian, A., Burstein, S. H. and Davis, R. J. (1995) The MAP kinase signal transduction pathway is activated by the endogenous cannabinoid anandamide. FEBS Letters 2-3, 133-136.
111. Weiss, F., Parsons, L. H., Schulteis, G., Hyytia, P., Lorang, M. T., Bloom, F. E. and Koob, G. F. (1996) Ethanol self-administration restores withdrawal-associated deficiencies in accumbal dopamine and 5-hydroxytryptamine release in dependent rats. Journal of Neuroscience 16, 3474-3485.
112. Welch, S. P., Huffman, J. W. and Lowe, J. (1998) Differential blockade of the antinociceptive effects of centrally administered cannabinoids by SR141716A. Journal of Pharmacology and Experimental Therapeutics 286, 1301-1308.
113. Werling, L. L., Puttfarcken, P. S. and Cox, B. M. (1988) Multiple agonist-affinity states of opioid receptors: regulation of binding by guanyl nucleotides in guinea pig cortical, NG108-15, and 7315c cell membranes. Molecular Pharmacology 33, 423-431.
114. Williams, R. J., Veale, M. A., Horne, P. and Kelly, E. (1993) Ethanol differentially regulates guanine nucleotide-binding protein alpha subunit expression in NG108-15 cells independently of extracellular adenosine. Molecular Pharmacology 43, 158-166.
115. Zhang, J. P., Xia, J. M. and Sun, G. Y. (1997) Chronic ethanol inhibits inositol metabolism in specific brain regions. Alcoholism: Clinical and Experimental Research 21, 716-720.
116. Zheng, Z., Barkai, A. and Hungund, B. L. (1996) Effects of ethanol on the incorporation of free fatty acids into cerebral membrane phospholipids. Neurochemistry International 28, 551-555.
117. Zhuang, S., Kittler, J., Grigorenko, E. V., Kirby, M. T., Sim, L. J., Hampson, R. E., Childers, S. R. and Deadwyler, S. A. (1998) Effects of long-term exposure to delta 9-THC on expression of cannabinoid receptor (CB1) mRNA in different rat brain regions. Molecular Brain Research 62, 141-149.